Lysophosphatidic acid and renal fibrosis. - Wikidata - awgldk - TriplyDB

Lysophosphatidic acid and renal fibrosis.

Lysophosphatidic acid and renal fibrosis.

http://www.wikidata.org/entity/Q36960382

about

Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.Lysophosphatidic acid-induced RhoA signaling and prolonged macrophage infiltration worsens fibrosis and fatty infiltration following rotator cuff tears.Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts Vascular involvement in systemic sclerosis (scleroderma).Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis.Anti-fibrotic effect of natural toxin bee venom on animal model of unilateral ureteral obstruction.Tubular cell phenotype in HIV-associated nephropathy: role of phospholipid lysophosphatidic acid.An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure.Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.Lysophosphatidic acid-1-receptor targeting agents for fibrosis.New renal drug development to face chronic renal disease.Lysophosphatidic acid induces migration of human lung-resident mesenchymal stem cells through the β-catenin pathway.Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling.Role of lysophosphatidic acid and its receptors in the kidney.Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.Autotaxin in Pathophysiology and Pulmonary Fibrosis.Overexpression and Functional Stabilization of Recombinant Human Lysophosphatidic Acid Receptor 1 Using an Amphiphatic Polymer Therapeutic potential of ginger against renal injury induced by carbon tetrachloride in rats

P2860

Q30407920-1260845C-2E1B-4C10-9837-FCAE293B204C Q33753311-CFC2819D-F230-4542-BE84-0207228EC5A6 Q33887329-91F028FB-18A9-4E9F-936A-92CF46FA94B8 Q33922964-2ACE29E7-21B6-4EBC-BE56-7D2BF68DF054 Q34025135-609700E0-7D09-4A9B-9008-0A314ACC87EF Q34292377-8B83DD95-31BD-47A4-8066-033E3C190B41 Q34310766-FD3F2D6D-1868-4B78-9994-7E4554BBB00E Q35557424-9B446A35-E2AD-49CE-B3A4-F368615ED538 Q35633633-5496530C-FBDD-4900-B114-065126CECFAC Q35736010-A51BEEE5-1F9D-46B0-AD2F-E0C4FAD127CF Q35808540-A764E377-5C54-4063-B2D3-4B639374D60F Q35924492-F8FF1607-1629-4567-822B-16271212975D Q36606173-8D135C7F-F85B-4F29-BBFD-3B412476ABD5 Q36771993-3AB52BDD-46D2-4643-9AEC-8750A16F381D Q37088270-DA02174C-E809-4BDE-955D-4A589C97CDDF Q37596497-B7F75BB2-6B23-4E02-A99B-78E3FB0DD93D Q37730679-1549BAC9-EF4C-47AA-8E11-57FCFADE662F Q37857284-241FB5A3-612D-4645-811F-E3FEAFC473E8 Q38246640-18A7126B-8025-4725-9A05-322B4127B6AD Q40430735-891C0C51-B431-4333-8C92-ED5B4C0B344B Q41680429-E552FFDB-9F0D-4761-83EC-44D9C72808ED Q43083914-60A0A276-D4DB-4CF3-8BC3-4FCC6CDCC97B Q47758727-28632588-B91A-43C6-8CF5-7B6D6ED9B55A Q53512767-D4EECF40-B86E-4F98-828A-00DFFD660B0B Q55420502-346365E0-0C22-4E66-AB08-222C6893A012 Q58340391-5D99CF9D-FF4A-4D36-A96F-9ABB2346B21A Q58915085-81FB10C5-D3ED-45A9-A1F9-6D2C37D0EBD0

P2860

Lysophosphatidic acid and renal fibrosis.

http://www.wikidata.org/entity/Q36960382

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Lysophosphatidic acid and renal fibrosis.

@en

type

label

Lysophosphatidic acid and renal fibrosis.

@en

prefLabel

Lysophosphatidic acid and renal fibrosis.

@en

P1433

Q36960382-4B21D9B5-EBBE-42BE-B0CF-2236FD495A7F

P1476

Q36960382-C04F5BF3-8957-4F95-B725-F2A4DE61E00D

P2093

Q36960382-73C6DFBC-1004-4573-AE7D-3FE4805C8E6E

Q36960382-F5F28B95-6F01-4AFD-A490-6CF6A70EA59A

Q36960382-FF54D71D-A979-4F6F-B710-A5DA568FD33B

P2860

Q36960382-0484EC7F-8A35-4CCE-B19E-130E75CB9767

Q36960382-06C886A6-29C8-4F0D-B72C-D1573F3A7226

Q36960382-133D4049-3A7E-4605-99F6-5ECA3D1F711D

Q36960382-17E608A8-1CA9-4125-BB52-04473AB70F13

Q36960382-1FC0FDEF-673E-43C2-BCDB-7C619EAC3C53

Q36960382-1FDF6F32-34ED-45DB-BD5F-F3F100263393

Q36960382-24FCC1EA-75F7-4A04-A1F3-BC721FF91577

Q36960382-2C2CB191-044E-47D0-A0D3-3BC9FF915CD7

Q36960382-310C6A06-4467-4EAD-B59D-181844CE81EC

Q36960382-319351F0-CB66-44B7-8EC5-324F5A05965C

P304

Q36960382-2D3825E2-1E70-4EA6-899E-608B8306ED18

P31

Q36960382-40F79188-6B7B-4773-9A4C-0B9267B6715F

P356

Q36960382-DDF25285-1481-4EC9-9FF0-63032CF33154

P407

Q36960382-C21FCFCF-382E-46DE-A249-E58C5817AB2E

P433

Q36960382-E706109F-DCCD-42DF-9D93-7A55C7B78E48

P478

Q36960382-5515BD91-D296-441C-ADE7-D98E5F4A7FE6

P50

Q36960382-619B7030-514E-4B91-8067-58D6FEB31435

Q36960382-69484920-552C-4444-82A3-B6C0519B1F30

Q36960382-6BC8AA82-E516-4C7C-9582-87EEDE435020

Q36960382-8AC851A2-510F-48D0-B0AC-5F96A91CAF59

Q36960382-AEC11045-35EB-40E8-A511-09C0B07EA077

Q36960382-B61E68E1-008C-44D6-AE7C-6DCE4A0181C2

P577

Q36960382-46631E46-B32D-4CC3-81F2-3E436F94D7D8

P5875

Q36960382-453D41BB-1C71-43AB-B09D-06E76F6F922C

P698

Q36960382-04467DBC-2EF3-41FC-9081-F7127C0A2C90

P932

Q36960382-FE9723AE-0997-4F90-BAAD-F0464222AFE5

P356

J.BBALIP.2008.04.001

P1433

Biochimica et Biophysica Acta

P1476

Lysophosphatidic acid and renal fibrosis

@en

P2093

Jean-Sébastien Saulnier-Blache

http://www.w3.org/2001/XMLSchema#string

Julien Gonzalez

http://www.w3.org/2001/XMLSchema#string

Sandra Grès

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic stellate cells: a target for the treatment of liver fibrosis

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis

Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)

Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins).

TGF-beta signaling and the fibrotic response

Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.

Obstructive nephropathy: towards biomarker discovery and gene therapy.

Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).

LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing.

P304

582-587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBALIP.2008.04.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

1781

http://www.w3.org/2001/XMLSchema#string

P50

Joost P Schanstra

Jean-Loup Bascands

Jean-Philippe Pradère

P577

2008-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5396401

http://www.w3.org/2001/XMLSchema#string

P698

18455518

http://www.w3.org/2001/XMLSchema#string

P932

2577601

http://www.w3.org/2001/XMLSchema#string